1. Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial
- Author
-
Albert Pierce, Roann Seay, David Boman, David E. Clark, Mitchell J. Cohen, Christopher W. Tuma, John B. Holcomb, Connie Colavecchia, Shannon W. Stephens, Deborah J. Novak, Evan G. Pivalizza, Richard D. Branson, Sarah E. Wade, Angela M. Beeler, Suzanne Bennett, Amanda S. Conroy, Eireen Mallari, Bryan A. Cotton, Kenji Inaba, Eberhard W. Fiebig, Lillian S. Kao, An Nguyen, Yu Bai, Karen J. Brasel, Sean O. Henderson, Kisha D. Arora-Nutall, Savitri N. Appana, Suzanne Wilson, Elaheh Rahbar, Tiffany Poole, David Milia, Adic Pérez, Skeeta Sobrian-Couroux, Lisa A. Baer, Keir J. Warner, Deborah M. Stein, Matthias Merkel, Magali J. Fontaine, Olga Kaslow, Monica D. Wong, Tahnee Groat, Dina Gomaa, Tyrone Burnett, Samantha J. Underwood, Lindsay Cattin, Amy Noland, Janice M. Hunt, Marisa B. Marques, Deborah J. del Junco, Henry E. Wang, Rhonda Hobbs, Eileen M. Bulger, Adam P. Arkin, Sam D. Gumbert, Elena Espino, Kelly Katzberg, Carolyn Williams, Marciano Reis, Martin A. Schreiber, Samuel M. Galvagno, Lisa Merkley, Christopher Barczak, Richard M. Scanlan, Allia Nelson, Rachael A. Callcut, John R. Hess, Thomas M. Scalea, Patrick L. Bosarge, Kellie Sheehan, Yao-Wei Willa Wang, Patricia Klotz, Marc P. Steurer, Nena Matijevic, Angela Wilson, Cynthia K. Shaffer, Jay A. Johannigman, Charles E. Wade, Preston C. Maxim, James J. McCarthy, Rodney McKeever, Jeanette M. Podbielski, Jean-Francois Pittet, Tom P. Aufderheide, Jordan A. Weinberg, Nathan J. White, Lynda Waddle-Smith, Peter Muskat, Jay G. Zhu, Susan E. Belo, Helen Hancock, Stephanie Panzer-Baggett, Craig D. Newgard, Jessica C. Cardenas, Sandro Rizoli, Judy Powell, Cheryl Y. Matsushita, Susanne May, Jennifer M. Watters, Seeta Kallam, Sandy Trpcic, Daniel T. Redford, Homer Tien, Sherri Flax, Laura Vincent, Pamela Walsh, Patricia M. Carey, Carolina Rodriguez, Christopher N. Miller, Erica Carpenter, Brittany S. Hula, Erika Gonzalez Rodriguez, David B. Hoyt, Ronald Chang, Joshua Nixon, Gerald van Belle, Mary F. Nelson, Ira A. Shulman, Jerome L. Gottschall, Nicholas Pawelczyk, Barto Nascimento, Erin E. Fox, Hongjian Zhu, Michael O. Gonzalez, Joanne Moore, Jennifer A. Daniel-Johnson, Brian G. Leroux, Janice M. Nelson, Anthony V. Herrera, Timothy J. Welch, Jeanne Callum, Terence O'Keeffe, Rhonda K. Cooke, Susan Knoll, Timothy C. Fabian, Bryce R.H. Robinson, Christine Wade, Andreas Grabinsky, Laurel L. Rokowski, Jeffrey D. Kerby, Alan Hubbard, Brittney J. Redick, Shuyan Wei, Hui Yang, Barbara C. Tilley, Sarah Baraniuk, Martin A. Croce, Kurt R. Denninghoff, Beth Miller, Rishika Sharma, and Michael Menchine
- Subjects
Adult ,Male ,Blood transfusion ,Time Factors ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Article ,law.invention ,Sepsis ,03 medical and health sciences ,Plasma ,0302 clinical medicine ,Injury Severity Score ,Randomized controlled trial ,law ,Interquartile range ,Medicine ,Humans ,Platelet ,Blood Transfusion ,Retrospective Studies ,Univariate analysis ,business.industry ,Platelet Count ,030208 emergency & critical care medicine ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Hospitalization ,Logistic Models ,Anesthesia ,Wounds and Injuries ,Surgery ,Female ,Syndecan-1 ,business - Abstract
Endotheliopathy of trauma is characterized by breakdown of the endothelial glycocalyx. Elevated biomarkers of endotheliopathy, such as serum syndecan-1 (Synd-1) ≥ 40 ng/mL, have been associated with increased need for transfusions, complications, and mortality. We hypothesized that severely injured trauma patients who exhibit elevated Synd-1 levels shortly after admission have an increased likelihood of developing sepsis.We analyzed a subset of patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial who survived at least 72 hours after hospital admission, and we determined elevated Synd-1 levels (≥ 40 ng/mL) 4 hours after hospital arrival. Sepsis was defined a priori as meeting systemic inflammatory response criteria and having a known or suspected infection. Univariate analysis was performed to identify variables associated with elevated Synd-1 levels and sepsis. Significant variables at a value of p0.2 in the univariate analysis were chosen by purposeful selection and analyzed in a mixed effects multivariate logistic regression model to account for the 12 different study sites.We included 512 patients. Of these, 402 (79%) had elevated Synd-1 levels, and 180 (35%) developed sepsis. Median Synd-1 levels at 4 hours after admission were 70 ng/dL (interquartile range [IQR] 36 to 157 ng/dL) in patients who did not develop sepsis, and 165 ng/dL [IQR 67 to 336 ng/dL] in those who did (p0.001). Adjusting for treatment arm and site, multivariable analyses revealed that elevated Synd-1 status, Injury Severity Score (ISS), and total blood transfused were significantly associated with an increased likelihood of developing sepsis.Elevated Synd-1 levels 4 hours after admission in severely injured adult trauma patients who survived the initial 72 hours after hospital admission are associated with subsequent sepsis.
- Published
- 2018